Keywords

• Atosiban
• Atosiban Acetate
• 90779-69-4

Quick Details

• ProName: Atosiban Acetate
• CasNo: 90779-69-4
• Molecular Formula: C45H71N11O14
• Appearance: white powder
• Application: halt premature labor
• DeliveryTime: 5 days
• PackAge: Bottle/bag or customized
• Port: Shanghai, Beijing, Shenzhen etc.
• ProductionCapacity: 50 Kilogram/Month
• Purity: 99%
• Storage: 2-8℃ sealed and away from light
• Transportation: Ocean and air shipping
• LimitNum: 1 Gram
• Related Substances: Effective ingredients >99%
• Residue on Ignition: 0.1
• Heavy Metal: 0
• Valid Period: 3 years

Superiority

GMP Manafacturer

High Purity

Competitive Price

Short Delivery Time

Jixianglong has peptide drug production workshop which approved by GMP standard. More than 300 sets advanced instruments for production and testing, such as Solid phase synthesizer, Preparative liquid chromatograph, Freeze dryer, High performance liquid chromatograph etc.

Atosiban acetate, a synthetic peptide, prevents preterm birth in 24 - 33 - week pregnant women. It's highly effective, acting as an antagonist to block oxytocin and inhibit contractions rapidly and sustainably. Safety - wise, it has few systemic side effects, is fetal - friendly, and reduces neonatal complication risks. Backed by extensive clinical trials, it's recommended in guidelines and well - received by clinicians. Administered via IV infusion, it's easy to use and offers flexible dosing. With a reliable supply chain and strict quality control, we provide it at a competitive price, enhancing its accessibility for healthcare and patients.

Jixianglong has 10 APIs production approvals, 16 invention patents achieved, including 5 compound patents.

Details

Atosiban Acetate CAS No.: 90779-69-4
Sequence: Mpa-D-Tyr(ET)-Ile-Thr-Asn-Cys-Pro-Orn-Gly-NH2  (Disulfide bridge: Mpa1-Cys6)
Atosiban Acetate is an inhibitor of the hormones oxytocin and vasopressin. It is used to halt premature labor(>18 Years, GA: 24~33 Weeks). Atosiban is a synthetic peptide oxytocin antagonist.

Company Profile 

Founded in 2011, Harbin Jixianglong Biotech Co., Ltd. is a is a professional high-tech company specializing in R&D and production of polypeptide pharmaceuticals. Our advanced industry chain occupied in R&D, approbation and industrialization of peptides API and preparation.
Jixianglong has peptide drug production workshop and pilot workshop for personalized cancer neoantigen peptide vaccine which approved by GMP standard. More than 300 sets advanced instruments for production and testing, such as Solid phase synthesizer, Preparative liquid chromatograph, Freeze dryer, High performance liquid chromatograph etc.
Jixianglong has 10 APIs production approvals, 16 invention patents achieved, including 5 compound patents.